ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 648556 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 648556; 2) Community: the network communities that were significantly associated with the response to NSC 648556; 3) Molecule: the relationships between components within communities and NSC 648556; 4) MDR: the compounds that were significantly associated with the NSC 648556.

NSC Compound Enrichment Correlation
NSC 718781 Erlotinib hydrochloride 0.029142074732756 -0.22087343
NSC 725098 Null 0.029142074732756 0.20969618
NSC 731704 1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. 0.029142074732756 0.19526271
NSC 732492 Null 0.029142074732756 0.048804522
NSC 743532 Null 0.029142074732756 0.33482256
NSC 748147 5-methyl-2-{[(2)-3-phenylprop-2-enoyl]amino}benzamide 0.029142074732756 0.50539243
NSC 748902 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] 0.029142074732756 0.47444548
NSC 753377 3-[2-(1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.029142074732756 0.522002
NSC 753598 Null 0.029142074732756 0.20164704
NSC 761832 (Z)-3-((1-(3,5-dimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)-5-methoxyindolin-2-one 0.029142074732756 0.29102582
Total:126  Current:95    [First] [Prev] [Next] [Last]